When it comes to life-threatening diseases, we are one family. We at Kiadis are focusing our research & development on NK cell therapeutics, leveraging the natural strengths of our immune systems to source the best cells for life.
Location: Netherlands, North Holland, Amsterdam
Founded date: 1997
Investors 2
| Date | Name | Website |
| - | Draper Esp... | draperespr... |
| - | Life Scien... | lspvc.com |
Mentions in press and media 14
| Date | Title | Description | Category | Author | Source |
| 14.05.2021 | KIADIS PHA... | Amsterdam, The Netherlands - K... | - | - | marketscre... |
| 13.05.2021 | Notice of ... | Amsterdam, The Netherlands, 13... | - | - | marketscre... |
| 13.04.2021 | Sanofi dec... | This is a joint press release ... | - | - | marketscre... |
| 09.04.2021 | Kiadis emp... | This is a press release by Kia... | - | - | marketscre... |
| 07.04.2021 | Kiadis Pha... | New strategic focus results in... | - | - | marketscre... |
| 30.03.2021 | Kiadis EGM... | This is a press release by Kia... | - | - | marketscre... |
| 15.02.2021 | Kiadis iss... | This is a press release by Kia... | - | - | globenewsw... |
| 12.02.2021 | Sanofi lau... | This is a joint press release ... | - | - | globenewsw... |
| 30.09.2020 | KIADIS PHA... | Interim Report For the six mo... | - | - | marketscre... |
| 30.09.2020 | Kiadis ann... | K-NK002 (HSCT): IND approved t... | - | - | marketscre... |
Show more